Progentec Diagnostics, Inc., was set up to explore and commercialize state of the art diagnostic interventions in therapeutic areas with a high level of unmet need. The company is collaborating with a number of research institutions and individuals around the world engaged in bringing the latest technological innovations to the field of diagnostics. The commitment to this cause is firmly rooted in our belief that better diagnostics would not only help in better and less costly management of diseases, but also help tremendously in reducing the incidence of diseases through early screening and detection.
Location: United States, Oklahoma, Oklahoma City
Employees: 11-50
Total raised: $5M
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | Plains Ven... | plainsvc.c... |
| - | XLerateHea... | xleratehea... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.01.2020 | Series A | $5M | - |
Mentions in press and media 7
| Date | Title | Description |
| 08.06.2021 | Progentec Announces Research Collaboration with GSK to Assess Proteomics and Digital Health Tools for Lupus (SLE) Care | |
| 02.02.2021 | Progentec Launches Care Management Platform for Lupus (SLE) Patients and Clinicians | |
| 10.01.2020 | Progentec Raises $5M in Series A Funding Led by Plains Venture Partners | – Commercializing aiSLE DX Flare Prediction Test, a new blood-based biomarker laboratory test for the prediction of systemic lupus erythematosus (SLE) flares |
| 09.01.2020 | Progentec Secures $5M in Series A Funding | Progentec, an Oklahoma City-based leader in the development of nextgen diagnostics and digital therapeutics for the management of autoimmune diseases, completed a $5m Series A funding. The round was led by Plains Venture Partners, the Oklah... |
| 08.01.2020 | Progentec Raises $5M in Series A | OKLAHOMA CITY, OK, Progentec has completed a $5 million Series A funding round. >> Click here for more funding data on Progentec >> To export Progentec funding data to PDF and Excel, click here Progentec, a leader in the ... |
| 14.11.2018 | Progentec Gains Additional Funding for Lupus Detection and Management Platforms | NOVEMBER 9, 2018 |
| 02.11.2018 | Progentec Diagnostics Completes Second Funding Round | Progentec Diagnostics, Inc., an Oklahoma City-based developer of technological innovations in the field of diagnostics, completed a second round of funding. The round was co-led by i2E and Chicago-based OCA Ventures, with participation from... |